Trial intelligence / Profile preview

Fluad in Immunocompromised Transplant Recipients

NCT01258023Phase 2Completed

Start
Nov 2010
Primary completion
Feb 2012
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of Fluzone Trivalent in influenza. Started Nov 2010; status: completed.

02

Drugs

Fluzone Trivalent
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01258023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01258023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call